How much revenue did Merck & Co generate this year?
Merck & Co has achieved a revenue of 64.47 B USD this year.
Merck & Co Revenue 2024
Merck & Co Revenue
64.47 B USD
Merck & Co Dividend yield
2.33 %
Ticker
MRK
ISIN
US58933Y1055
WKN
A0YD8Q
In 2024, Merck & Co's sales reached 64.47 B USD, a 7.24% difference from the 60.12 B USD sales recorded in the previous year.
The Merck & Co Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 72.55 | 60,93 |
| 2028e | 75.36 | 58,65 |
| 2027e | 73.39 | 60,23 |
| 2026e | 72.51 | 60,96 |
| 2025e | 68.63 | 64,40 |
| 2024e | 64.47 | 68,56 |
| 2023 | 60.12 | 73,53 |
| 2022 | 59.28 | 70,98 |
| 2021 | 48.7 | 72,81 |
| 2020 | 41.52 | 72,10 |
| 2019 | 39.12 | 71,73 |
| 2018 | 42.29 | 69,11 |
| 2017 | 40.12 | 68,50 |
| 2016 | 39.81 | 66,08 |
| 2015 | 39.5 | 63,22 |
| 2014 | 42.24 | 64,05 |
| 2013 | 44.03 | 63,61 |
| 2012 | 47.27 | 65,21 |
| 2011 | 48.05 | 64,89 |
| 2010 | 45.99 | 60,00 |
| 2009 | 27.43 | 67,12 |
| 2008 | 23.85 | 76,59 |
| 2007 | 24.2 | 74,62 |
| 2006 | 22.64 | 73,49 |
| 2005 | 22.01 | 76,61 |
| 2004 | 22.97 | 78,38 |
Merck & Co Aktienanalyse
What does Merck & Co do?
The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Merck & Co's Sales Figures
The sales figures of Merck & Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Merck & Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Merck & Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Merck & Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Merck & Co Stock
How much was the turnover of the company Merck & Co compared to the previous year?
The revenue of Merck & Co has increased by 7.24% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Merck & Co?
The revenue of Merck & Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Merck & Co measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Merck & Co so important for investors?
The revenue of Merck & Co is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Merck & Co pay?
Over the past 12 months, Merck & Co paid a dividend of 2.96 USD . This corresponds to a dividend yield of about 2.33 %. For the coming 12 months, Merck & Co is expected to pay a dividend of 3.37 USD.
What is the dividend yield of Merck & Co?
The current dividend yield of Merck & Co is 2.33 %.
When does Merck & Co pay dividends?
Merck & Co pays a quarterly dividend. This is distributed in the months of July, October, January, April.
How secure is the dividend of Merck & Co?
Merck & Co paid dividends every year for the past 26 years.
What is the dividend of Merck & Co?
For the upcoming 12 months, dividends amounting to 3.37 USD are expected. This corresponds to a dividend yield of 2.66 %.
In which sector is Merck & Co located?
Merck & Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck & Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck & Co from 4/5/2024 amounting to 0.77 USD, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
When did Merck & Co pay the last dividend?
The last dividend was paid out on 4/5/2024.
What was the dividend of Merck & Co in the year 2023?
In the year 2023, Merck & Co distributed 2.8 USD as dividends.
In which currency does Merck & Co pay out the dividend?
The dividends of Merck & Co are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck & Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck & Co
Our stock analysis for Merck & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
